To further clarify the nature of the association between metformin use and OS in EGFR-TKI-treated and diabetic NSCLC patients, subgroup analyses were conducted focusing on EGFR-TKI-treated patients (according to comorbidity of diabetes mellitus) and diabetic patients (according to treatment type). This evidence concerns the gene EGFR and diabetes mellitus.